These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4031516)

  • 61. Peritonitis in children receiving continuous ambulatory peritoneal dialysis.
    McClung MR
    Pediatr Infect Dis; 1983; 2(4):328-32. PubMed ID: 6889164
    [No Abstract]   [Full Text] [Related]  

  • 62. Intracatheter amphotericin B retention for fungal peritonitis in continuous ambulatory peritoneal dialysis.
    Lee SH; Chiang SS; Hseih SJ; Shen HM
    J Formos Med Assoc; 1995 Mar; 94(3):132-4. PubMed ID: 7613245
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
    Fenton P
    J Antimicrob Chemother; 1984 May; 13(5):411-3. PubMed ID: 6735960
    [No Abstract]   [Full Text] [Related]  

  • 64. The effect of peritonitis on the distribution of cefuroxime in patients undergoing continuous ambulatory peritoneal dialysis.
    McIntosh ME; Smith WG; Junor BJ; Forrest G; Brodie MJ
    Scott Med J; 1984 Apr; 29(2):117-8. PubMed ID: 6531683
    [No Abstract]   [Full Text] [Related]  

  • 65. Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis.
    Buggy BP; Schaberg DR; Swartz RD
    Am J Med; 1984 Jun; 76(6):1035-40. PubMed ID: 6731461
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chemotherapy and/or removal of the peritoneal catheter in the management of fungal peritonitis complicating CAPD?
    Cecchin E; De Marchi S; Panarello G; Tesio F
    Nephron; 1985; 40(2):251-2. PubMed ID: 4039798
    [No Abstract]   [Full Text] [Related]  

  • 67. Vancomycin and tobramycin in the treatment of CAPD peritonitis.
    Gruer LD; Turney JH; Curley J; Michael J; Adu D
    Nephron; 1985; 41(3):279-82. PubMed ID: 4058628
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Campylobacter peritonitis complicating continuous ambulatory peritoneal dialysis: report of three cases and review of the literature.
    Elshafie SS; Asim M; Ashour A; Elhiday AH; Mohsen T; Doiphode S
    Perit Dial Int; 2010; 30(1):99-104. PubMed ID: 20056988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical analysis of chronic peritoneal dialysis related peritonitis in children.
    Tsai YC; Tsai TC; Tsaf JD; Huang FY; Lin CC; Sheu JC
    Acta Paediatr Taiwan; 2006; 47(2):72-6. PubMed ID: 16927631
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A case of Campylobacter jejuni peritonitis in a patient undergoing peritoneal dialysis.
    Binukrishnan S; Howse M; Neal T; Ahmad R
    J Med Microbiol; 2001 Oct; 50(10):935. PubMed ID: 11599746
    [No Abstract]   [Full Text] [Related]  

  • 71. Rifampin use in peritoneal dialysis.
    Zimmerman SW; Johnson CA
    Perit Dial Int; 1989; 9(4):241-3. PubMed ID: 2488374
    [No Abstract]   [Full Text] [Related]  

  • 72. Adult and pediatric peritonitis rates in a home dialysis program: comparison of continuous ambulatory and continuous cycling peritoneal dialysis.
    Howard RL; Millspaugh J; Teitelbaum I
    Am J Kidney Dis; 1990 Nov; 16(5):469-72. PubMed ID: 2239939
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gardnerella vaginalis (hemophilus vaginalis), an unusual cause of peritonitis in C.A.P.D.
    De Paepe M; Lameire N; Claeys G; Verschraegen G
    Clin Exp Dial Apheresis; 1982; 6(4):197-204. PubMed ID: 6985031
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peritonitis caused by Mycobacterium kansasii in a patient undergoing continuous ambulatory peritoneal dialysis.
    Giladi M; Lee BE; Berlin OG; Panosian CB
    Am J Kidney Dis; 1992 Jun; 19(6):597-9. PubMed ID: 1595710
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Failure to cure Mycobacterium gordonae peritonitis associated with continuous ambulatory peritoneal dialysis.
    Harro C; Braden GL; Morris AB; Lipkowitz GS; Madden RL
    Clin Infect Dis; 1997 May; 24(5):955-7. PubMed ID: 9142800
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of peritonitis incidence in CAPD and automated peritoneal dialysis.
    Basile C; De Padova F
    Nephrol Dial Transplant; 2001 Sep; 16(9):1957-8. PubMed ID: 11522896
    [No Abstract]   [Full Text] [Related]  

  • 77. Increased peritoneal permeability in patients with peritonitis undergoing continuous ambulatory peritoneal dialysis.
    McIntosh ME; Smith WG; Junor BJ; Forrest G; Brodie MJ
    Eur J Clin Pharmacol; 1985; 28(2):187-91. PubMed ID: 3987798
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Candida peritonitis-inefficacy of amphotericin-B and 5-fluorocytosine treatment.
    Pomeranz A; Reichenberg Y; Mor J; Drukker A
    Int J Pediatr Nephrol; 1983 Jun; 4(2):127-8. PubMed ID: 6618770
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Our protocol in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis].
    Kostić S; Ljuvenović S; Velicković R; Stefanović V; Raicević R; Cukuranović R; Veljković S; Djordjević V; Malobabić Z
    Srp Arh Celok Lek; 1996; 124 Suppl 1():149-51. PubMed ID: 9102884
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment and prevention of relapses of CAPD Pseudomonas peritonitis.
    Pasadakis P; Thodis E; Eftimimiadou A; Panagoutsos S; Papazoglou D; Kaliengidou M; Kartali S; Vargemezis V
    Adv Perit Dial; 1993; 9():206-10. PubMed ID: 8105925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.